Idiopathic thrombocytopenic purpura of childhood: A problem-oriented review of the management

Transfusion and Apheresis Science

Volumn 28, Issue 3, 2003, Pages 243-248

  Kühne, Thomas ^a  

^a UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

Author keywords

Blood platelets; Child; Evidence based medicine; Idiopathic thrombocytopenic purpura; Management; Pediatrics

Indexed keywords

CORTICOSTEROID; IMMUNOGLOBULIN; PREDNISONE;

BLEEDING; BLEEDING TENDENCY; BRAIN HEMORRHAGE; CHILD; CHILDHOOD; CLINICAL FEATURE; CLINICAL TRIAL; DISEASE DURATION; EVIDENCE BASED MEDICINE; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; PETECHIA; PROPHYLAXIS; REVIEW; RISK; THROMBOCYTE; THROMBOCYTE COUNT; TREATMENT PLANNING;

EID: 0037410061     PISSN: 14730502     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1473-0502(03)00042-9     Document Type: Review

References (34)

1. Hoffman M., Monroe D.M. III A cell-based model of hemostasis. Thromb. Haemost. 85:2001;958-965.
2. Harrington W.J., Minnich V., Hollingsworth J.W., Moore C.V. Demonstration of a thrombocytopenic factor in the blood of patients with thrombocytopenic purpura. J. Lab. Clin. Med. 38:1951;1-10.
3. Ballem P.J., Segal G.M., Stratton J.R., Gernsheimer T., Adamson J.W., Slichter S.J. Mechanisms of thrombocytopenia in chronic autoimmune thrombocytopenic purpura. Evidence of both impaired platelet production and increased platelet clearance. J. Clin. Invest. 80:1987;33-40.
4. Tsubakio T., Tani P., Curd J.G., McMillan R. Complement activation in vitro by antiplatelet antibodies in chronic immune thrombocytopenic purpura. Br. J. Haematol. 63:1986;293-300.
5. Wentworth P. Jr., Jones L.H., Wentworth A.D., Zhu X., Larsen N.A., Wilson I.A.et al. Antibody catalysis of the oxidation of water. Science. 293:2001;1806-1811.
6. Kühne T., Imbach P., Bolton-Maggs P.H.B., Berchtold W., Blanchette V., Buchanan G.R., for the Intercontinental Childhood ITP Study Group Newly diagnosed idiopathic thrombocytopenic purpura in childhood: an observational study. Lancet. 358:2001;2122-2125.
7. Tamary H., Kaplinsky C., Levy I., Cohen I.J., Yaniv I., Stark B.et al. Chronic childhood idiopathic thrombocytopenia purpura: long-term follow-up. Acta Paediatr. 83:1994;931-934.
8. George J.N., Woolf S.H., Raskob G.E., Wasser J.S., Aledort L.M., Ballem P.J.et al. Warrier I: idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for The American Society of Hematology. Blood. 88:1996;3-40.
9. Aronis S., Platokouki H., Mitsika A., Haidas S., Constantopoulos A. Seventeen years of experience with chronic idiopathic thrombocytopenic purpura in childhood. Is therapy always better. Pediatr. Hematol. Oncol. 11:1994;487-498.
10. Reid M.M. Chronic idiopathic thrombocytopenic purpura: incidence, treatment, and outcome. Arch. Dis. Child. 72:1995;125-128.
11. Rand M.L., Wright J.F. Virus-associated idiopathic thrombocytopenic purpura. Transfus. Sci. 19:1998;253-259.
12. Farrington P., Pugh S., Colville A., Flower A., Nash J., Morgan-Capner P.et al. A new method for active surveillance of adverse events from diphtheria/tetanus/pertussis and measles/mumps/rubella vaccines. Lancet. 345:1995;567-569.
13. Semple J.W. Immunobiology of T helper cells and antigen-presenting cells in autoimmune thrombocytopenic purpura (ITP). Acta. Paediatr. Suppl. 424:1998;41-45.
14. Foster C.B., Zhu S., Erichsen H.C., Lehrnbecher T., Hart E.S., Choi E.et al., for the Early Chronic ITP Study Group Polymorphisms in inflammatory cytokines and Fcγ receptors in childhood chronic immune thrombocytopenic purpura: a pilot study. Br. J. Haematol. 113:2001;596-599.
15. Yoshimura C., Nomura S., Nagahama M., Ozaki Y., Kagawa H., Fukuhara S. Plasma-soluble Fas (APO-1, CD95) and soluble Fas ligand in immune thrombocytopenic purpura. Eur. J. Haematol. 64:2000;219-224.
16. Sutor A.H., Harms A., Kaufmehl K. Acute immune thrombocytopenia (ITP) in childhood: retrospective and prospective survey in Germany. Semin. Thromb. Hemost. 27:2001;253-267.
17. Lee S.M., Choi E.J., Lee K.S., Ahn H.S. Childhood acute immune thrombocytopenic purpura - multicenter study of Korean pediatric hematology & oncology group. Int. J. Hematol. 76(Suppl 1):2002;5.
18. Kühne T., Berchtold W., Be T.V., Binh T.V., Imbach P. Ethnicity and environment may affect the phenotype of immune thrombocytopenic purpura in children. Pediatr. Res. 48:2000;374-379.
19. Medeiros D., Buchanan G.R. Major hemorrhage in children with idiopathic thrombocytopenic purpura: immediate response to therapy and long-term outcome. J. Pediatr. 133:1998;334-339.
20. Available from: www.unibas.ch/itpbasel.
21. George J.N., Davidoff F. Idiopathic thrombocytopenic purpura: lessons from a guideline. Ann. Intern. Med. 126:1997;317-318.
22. Kühne T., Elinder G., Blanchette V.S., Garvey B. Current management issues of childhood and adult immune thrombocytopenic purpura. Acta Paediatr. 424(Suppl):1998;75-81.
23. Bolton-Maggs P.H.B., Moon I. Assessment of UK practice for management of acute childhood idiopathic thrombocytopenic purpura against published guidelines. Lancet. 350:1997;620-623.
24. Lilleyman J.S. Intracranial haemorrhage in idiopathic thrombocytopenic purpura. Paediatric Haematology Forum of the British Society for Haematology. Arch. Dis. Child. 71:1994;251-253.
25. Iyori H., Bessho F., Ookawa H., Konishi S., Shirahata A., Miyazaki S., Japanese Study Group on childhood ITPet al. Intracranial hemorrhage in children with immune thrombocytopenic purpura. Ann. Hematol. 79:2000;691-695.
26. Imbach P., Wagner H.P., Berchtold W., Gaedicke G., Hirt A., Joller P.et al. Intravenous immunoglobulin versus oral corticosteroids in acute immune thrombocytopenic purpura in childhood. Lancet. 2:1985;464-468.
27. Lilleyman J.S. Management of childhood idiopathic thrombocytopenic purpura. Br. J. Haematol. 105:1999;871-875.
28. McWilliams N.B., Maurer H.M. Acute idiopathic thrombocytopenic purpura in children. Am. J. Hematol. 7:1979;87-96.
29. Sartorius L.A. Steroid treatment of idiopathic thrombocytopenic purpura in children. Preliminary results of a randomized cooperative study. Am. J. Pediatr. Hematol. Oncol. 6:1984;165-169.
30. Buchanan G.R., Holtkamp C.A. Prednisone therapy for children with newly diagnosed idiopathic thrombocytopenic purpura. A randomized clinical trial. Am. J. Pediatr. Hematol. Oncol. 6:1984;355-361.
31. Blanchette V.S., Luke B., Andrew M., Sommerville-Nielsen S., Barnard D., De Veber B.et al. A prospective, randomized trial of high-dose intravenous immune globulin Gtherapy, oral prednisone therapy, and no therapy in childhood acute immune thrombocytopenic purpura. J. Pediatr. 123:1993;989-995.
32. Fujisawa K., Iyori H., Ohkawa H., Konishi S., Bessho F., Shirahata A., Japanese Study Group on Childhood ITPet al. A prospective, randomized trial of conventional, dose-accelerated corticosteroids and intravenous immunoglobulin in children with newly diagnosed idiopathic thrombocytopenic purpura. Int. J. Hematol. 72:2000;376-383.
33. Eden O.B., Lilleyman J.S. Guidelines for management of idiopathic thrombocytopenic purpura. The British Paediatric Haematology Group Arch. Dis. Child. 67:1992;1056-1058.
34. Dickerhoff R., Von Ruecker A. The clinical course of immune thrombocytopenic purpura in children who did not receive intravenous immunoglobulins or sustained prednisone treatment. J. Pediatr. 137:2000;629-632.